Figure 4
From: BA-j as a novel CDK1 inhibitor selectively induces apoptosis in cancer cells by regulating ROS
Expression of Fas/FasL in Hep G2 cells treated with BA-j for 48 h compared with HCPT treatment.
2 μM HCPT was used.
Figure 4 | Scientific Reports
